Position in EPRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$333,355
-$101,045 QoQ
Shares Held
50,432
-15.9% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 68 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 20261832 Asset Management L.P. holds $312,434,848 across 9 Biotechnology names. EPRX ranks #9 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
157,940 | $146,531,993 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
309,200 | $57,906,976 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
538,500 | $43,893,135 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
99,300 | $36,906,831 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
186,300 | $10,235,322 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
28,000 | $6,853,560 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
88,100 | $5,004,961 | |
| 8 | INCY |
Incyte Corp
|
42,067 | $4,768,715 |
All Filings in EPRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $333,355 | 50,432 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $434,400 | 60,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $242,641 | 32,138 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||